Of note, a rise in plasma GFAP levels is also seen in Lewy body dementia [157] and FTD [165], suggesting that plasma GFAP levels are reflective of the reactive astrogliosis occurring in neurodegeneration more broadly. The gene discussed is GFAP; the disease is Lewy body dementia.